Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

California Stem Cell Agency Awards $3.4M Grant to the Jackson Laboratory

24.06.2009
The Jackson Laboratory has received a $3.4 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, to develop new mouse models of human disease that can be used to test innovative stem cell treatments.

The Jackson Laboratory has received a $3.4 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, to help speed the development of new therapies for cancer, Alzheimer’s, Parkinson’s and other diseases.

The nonprofit Jackson Laboratory, based in Bar Harbor, has a facility in Sacramento that provides research services to the West Coast biomedical community. The Jackson Laboratory—West will use the CIRM grant to develop new mouse models of human disease that can be used to test innovative stem cell treatments.

Jackson Laboratory President and CEO Rick Woychik, Ph.D., says, “Stem cells have tremendous potential for treating human diseases because of their unique capacity to develop into any cell type in the body. However, before stem cell therapies are used in human patients, it is critical to test their efficacy and safety using a research animal that has the relevant disease.”

The laboratory mouse, widely recognized as the premier mammalian model for studying human disease, is the optimal organism for these preclinical studies, Woychik says.

CIRM issued the award as part of a $40.6 million package of new and continuing grants to California universities and public and private research laboratories. The Jackson project is among those CIRM describes as “early translational” and “intended to either lead to a drug candidate for an unmet medical need or address a bottleneck in the development of new therapies.”

Woychik notes that the grant illustrates the value of having established a presence for the Laboratory in California. “Being located in the world’s largest biomedical research community brings us opportunities that would otherwise be unavailable to us,” he says. “This grant, like more than 90 percent of our funding, comes from outside Maine.”

Leon Hall, Ph.D., is a program director of The Jackson Laboratory—West group that will develop the new mouse models. While mouse models are available for a wide range of human diseases, Hall says, “The Jackson Laboratory now has immune-deficient mice that support long-term transplantation with human stem cells. This grant will allow us to develop new and more relevant mouse models of disease that can sustain human stem cell engraftment. This should eliminate a major barrier to the translation of basic stem cell research to the clinic.”

Chuck Hewett, Ph.D., Jackson VP and chief operating officer, added that “once these new models are developed, The Jackson Laboratory—West will use its new, state-of-the-art facilities to ensure efficient delivery of these mice within California and to provide services to stem cell investigators to reveal information about disease progression.”

The Jackson Laboratory established JAX—West at a small facility in West Sacramento in 2001. In late 2008 JAX—West moved to a larger facility in Sacramento, with about 85 employees on site. Providing a pathogen-free environment for the laboratory animals, the facility meets the highest federal, state and voluntary standards for animal care, genetic quality control and health status, Hewett notes.

Joyce Peterson | Newswise Science News
Further information:
http://www.jax.org

Further reports about: CIRM Laboratory Medicine Stem cell innovation cell death human diseases mouse model

More articles from Awards Funding:

nachricht IVAM Marketing Prize recognizes convincing technology marketing for the tenth time
22.08.2017 | IVAM Fachverband für Mikrotechnik

nachricht RNA: a vicious pathway to cancer ?
14.08.2017 | Goethe-Universität Frankfurt am Main

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Heating quantum matter: A novel view on topology

22.08.2017 | Physics and Astronomy

Stretchable biofuel cells extract energy from sweat to power wearable devices

22.08.2017 | Power and Electrical Engineering

New technique to treating mitral valve diseases: First patient data

22.08.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>